Table 1.
Patient Characteristics by Race
| White/Caucasian n = 2072 | Black/African American n = 601 | P-Value | |
|---|---|---|---|
| Age | 59.8 ± 12.3 | 56.9 ± 11.9 | < 0.001 |
| Sex | < 0.001 | ||
| Male | 1476 (71.2%) | 324 (53.9%) | |
| Female | 596 (28.8%) | 277 (46.1%) | |
| BMI | 29.4 ± 6.0 | 30.0 ± 7.3 | 0.043 |
| Smoking Status | < 0.001 | ||
| Current (<30d) | 782 (37.9%) | 273 (45.9%) | |
| Former (>=30d) | 702 (34.0%) | 148 (24.9%) | |
| Never (or <100 total) | 580 (28.1%) | 174 (29.2%) | |
| Dyslipidemia | 1072 (51.7%) | 262 (43.6%) | < 0.001 |
| Hypertension | 1255 (60.6%) | 463 (77.0%) | < 0.001 |
| Diabetes | 518 (25.0%) | 246 (40.9%) | < 0.001 |
| Prior PCI | 457 (22.1%) | 94 (15.6%) | < 0.001 |
| Prior CABG | 275 (13.3%) | 52 (8.7%) | 0.002 |
| Prior MI | 414 (20.0%) | 147 (24.5%) | 0.018 |
| Peripheral Arterial Disease | 109 (5.3%) | 29 (4.8%) | 0.671 |
| Prior CVA | 67 (3.2%) | 44 (7.3%) | < 0.001 |
| Prior TIA | 47 (2.3%) | 9 (1.5%) | 0.245 |
| Chronic Heart Failure | 109 (5.3%) | 110 (18.3%) | < 0.001 |
| Chronic Renal Failure | 74 (3.6%) | 106 (17.6%) | < 0.001 |
| Chronic Lung Disease | 154 (7.4%) | 59 (9.8%) | 0.057 |
| LV Systolic Function | < 0.001 | ||
| Normal | 1178 (57.7%) | 367 (61.8%) | |
| Mild | 458 (22.4%) | 89 (15.0%) | |
| Moderate | 288 (14.1%) | 51 (8.6%) | |
| Severe | 117 (5.7%) | 87 (14.6%) | |
| Diseased Vessels | < 0.001 | ||
| 0 | 101 (5.1%) | 82 (17.5%) | |
| 1 | 818 (41.6%) | 192 (41.0%) | |
| 2 | 562 (28.6%) | 96 (20.5%) | |
| 3 | 485 (24.7%) | 98 (20.9%) | |
| ACS Type | < 0.001 | ||
| STEMI | 1006 (48.6%) | 166 (27.6%) | |
| NSTEMI | 912 (44.0%) | 385 (64.1%) | |
| UA | 154 (7.4%) | 50 (8.3%) | |
| Beta Blocker on Arrival | 638 (30.8%) | 224 (37.3%) | 0.003 |
| GRACE Risk Score | 97.9 ± 29.1 | 100.7 ± 30.1 | 0.043 |
| Revascularization Type | < 0.001 | ||
| None | 377 (18.2%) | 308 (51.2%) | |
| PCI | 1513 (73.0%) | 254 (42.3%) | |
| CABG | 182 (8.8%) | 39 (6.5%) |